Albemarle(US:ALB) ZACKS·2026-02-02 23:51Company Performance - Albemarle's stock closed at $164.93, reflecting a decrease of -3.34% from the previous day, underperforming the S&P 500 which gained 0.54% [1] - The stock has increased by 18.55% over the past month, outperforming the Basic Materials sector's gain of 7.23% and the S&P 500's gain of 0.74% [1] Upcoming Earnings - Albemarle's earnings report is scheduled for February 11, 2026, with projected earnings per share (EPS) of -$0.52, indicating a 52.29% increase from the same quarter last year [2] - The Zacks Consensus Estimate for revenue is $1.35 billion, representing a 9.58% increase from the previous year [2] Fiscal Year Estimates - For the entire fiscal year, the Zacks Consensus Estimates predict an EPS of -$0.9 and revenue of $5.06 billion, showing changes of +61.54% and 0% respectively from the prior year [3] - Recent adjustments to analyst estimates reflect shifting business dynamics, with positive revisions indicating analysts' confidence in the company's performance [3] Zacks Rank and Performance - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has a strong track record, with 1 rated stocks averaging an annual return of +25% since 1988 [5] - Albemarle currently holds a Zacks Rank of 1 (Strong Buy), with a 180.18% rise in the Zacks Consensus EPS estimate over the past month [5] Valuation Metrics - Albemarle has a Forward P/E ratio of 48.83, significantly higher than the industry average Forward P/E of 16.91 [6] - The company has a PEG ratio of 3.05, which is in line with the Chemical - Diversified industry average [6] Industry Context - The Chemical - Diversified industry, part of the Basic Materials sector, holds a Zacks Industry Rank of 210, placing it in the bottom 15% of over 250 industries [7] - The Zacks Industry Rank indicates that top-rated industries outperform the bottom half by a factor of 2 to 1 [7]